EXERTION is part of the AGITG Endorsed Study Model (please click here to find out more)
If you think this trial is relevant to your situation, please contact your Cancer Specialist to discuss further.
A novel strategy for exercise delivery: optimising use of time during chemotherapy infusion for colon cancer patients
Purpose of the Study
Exercise is beneficial for managing side effects of chemotherapy for colon cancer and improving survival outcomes. Recognising the vital role exercise has during cancer treatment and survivorship, the Clinical Oncology Society of Australia (COSA) recommends exercise be integrated into routine cancer care. Despite the known benefits and advocacy, less than 10% of people with cancer meet exercise guidelines. It is critical we develop new strategies to enable and empower individuals with colon cancer to be physically active.
An unexplored strategy for exercise delivery is radically transforming the time during chemotherapy infusion.
The aim of EXERTION is to systematically develop an exercise intervention delivered during chemotherapy infusion for colon cancer and provide proof-of-principle of this approach.
Dr Jasmine Yee
DETAILED INFORMATION AVAILABLE
If you think this clinical trial may be relevant to your patient or to discuss further, please contact the Clinical Trial team.